TOTAL PROTEIN GEN.2
Received Feb 11, 2026 · Event occurred Jan 21, 2026
Report 1823260-2026-00476 · MDR key 24315633
Device
Generic name
Biuret Total Protein
Manufacturer
Roche DiagnosticsCatalog number
08058652190
Lot number
ASKU
Product problems
- High Test Results
- Non Reproducible Results
Patient
NA · Unknown
- No Clinical Signs, Symptoms or Conditions
Narrative
Additional Manufacturer Narrative
CALIBRATION WAS LAST PERFORMED ON 28-DEC-2025. THE ALARM TRACE DID NOT CONTAIN A CONSPICUOUS EVENT. IT WAS DETERMINED THAT THE SAMPLES WERE NOT CENTRIFUGED BEFORE BEING TESTED. THE ROOT CAUSE OF THE EVENT WAS FOUND TO BE CONSISTENT WITH PRE-ANALYTICAL SAMPLE HANDLING ISSUES.
Additional Manufacturer Narrative
THE ANALYZER SERIAL NUMBER IS (B)(6). THE INVESTIGATION IS ONGOING.
Description of Event or Problem
THERE WAS AN ALLEGATION OF QUESTIONABLE TINA-QUANT C-REACTIVE PROTEIN IV (CRP), TOTAL PROTEIN GEN.2 (TP), AND ALKALINE PHOSPHATASE ACC. TO IFCC GEN.2 (ALP) RESULTS FOR 2 PATIENT SAMPLES ON A COBAS C 503 ANALYTICAL UNIT. THIS MEDWATCH WILL COVER TP. REFER TO MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE CRP RESULTS AND MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE ALP RESULTS. THE CUSTOMER WAS PROMPTED TO REPEAT THE PATIENT SAMPLES AS THEY LOOKED LIKE THEY HAD NOT BEEN CENTRIFUGED. SAMPLE 1 HAD AN INITIAL CRP RESULT OF 0.362 MG/DL AND AN INITIAL TP RESULT OF 10.6 G/DL. THE REPEAT CRP RESULT WAS 0.62 MG/DL AND THE REPEAT TP RESULT WAS 7.0 G/DL. SAMPLE 2 HAD AN INITIAL ALP RESULT OF 159 U/L. THE REPEAT RESULT WAS 88 U/L. THE REPEAT RESULTS WERE DEEMED CORRECT. NO QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY.